9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP): A novel agent with anti-human immunodeficiency virus activity in vitro and potent anti-moloney murine sarcoma virus activity in vivo
- 36 Downloads
9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) is a potent inhibitor of the replication of human immunodeficiency virus (HIV) in human T-lymphocyte MT-4 cells (50% effective dose: 2 µM). PMEDAP strongly inhibited Moloney murine sarcoma virus (MSV)-induced transformation of murine C3H/3T3 embryo fibroblasts and caused a dose-dependent suppression of tumor formation and mortality in newborn mice inoculated with MSV. Even at a dose as low as 0.25 mg/kg/day, PMEDAP effected a significant delay in tumor appearance and an enhancement of the survival rate of tumor-bearing mice. PMEDAP proved fivefold more efficacious as an anti-MSV agent than 9-(2-phosphonylmethoxyethyl)-adenine (PMEA), which has been previously shown to exhibit strong antiretroviral efficacy in vivo. However, PMEDAP was also more toxic, so that its therapeutic index was equivalent to that of PMEA.
KeywordsHuman Immunodeficiency Virus Adenine Effective Dose Tumor Formation Therapeutic Index
Unable to display preview. Download preview PDF.
- 1.Barré-Sinoussi, F., Chermann, J. C., Rey, R., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., Rozenbaum, W., Montagnier, L. Isolation of a T cell lymphocytic virus from a patient at risk for acquired immunodeficiency syndrome (AIDS). Science 1983, 220: 868–871.PubMedGoogle Scholar
- 2.Gallo, R. C., Salahuddin, S. Z., Popovic, M., Sherer, G., Kaplan, M., Haynes, B. F., Parker, T. J., Redfield, R., Oleske, J., Safai, B., White, G., Foster, P., Markham, P. D. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984, 224: 500–503.PubMedGoogle Scholar
- 7.Balzarini, J., Pauwels, R., Baba, M., Herdewijn, P., De Clercq, E., Broder, S., Johns, D. G. The in vitro and in vivo anti-retrovirus activity and intracellular metabolism of 3′-azido-2′,3′-dideoxythymidine and 2′,3′-dideoxycytidine are highly dependent on the cell species. Biochemical Pharmacology 1988, 37: 897–903.CrossRefPubMedGoogle Scholar
- 8.Balzarini, J., Naesens, L., Herdewijn, P., Rosenberg, I., Holý, A., Pauwels, R., Baba, M., Johns, D. G., De Clercq, E. Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent. Proceedings of the National Academy of Sciences of the USA 1989, 86: 332–336.PubMedGoogle Scholar
- 11.Holý, A., Rosenberg, I. Synthesis of 9-(2-phosphonylmethoxyethyl)adenine and related compounds. Collection of Czechoslovak Chemical Communications 1987, 52: 2801–2809.Google Scholar
- 14.Balzarini, J., Pauwels, R., Baba, M., Robins, M. J., Zou, R., Herdewijn, P., De Clercq, E. The 2′,3′-dideoxyriboside of 2,6-diaminopurine selectively inhibits human immunodeficiency virus (HIV) replication in vitro. Biochemical and Biophysical Research Communications 1987, 145: 269–276.CrossRefPubMedGoogle Scholar
- 16.De Clercq, E., Merigan, T. C. Moloney sarcoma virus-induced tumors in mice: inhibition or stimulation by (poly rI):(poly rC). Proceedings of the Society for Experimental Biology and Medicine 1971, 137: 590–594.Google Scholar